Corrigendum: mTORC1-dependent translation of collapsin response mediator protein-2 drives neuroadaptations underlying excessive alcohol-drinking behaviors (Molecular Psychiatry (2017) 22 (89-101) DOI: 10.1038/mp.2016.12);MTORC1-dependent translation of collapsin response mediator protein-2 drives neuroadaptations underlying excessive alcohol-drinking behaviors

Molecular Psychiatry

Volumn 22, Issue 1, 2017, Pages 89-101

  Liu, F ^a,b   Laguesse, S ^a   Legastelois, R ^a,c   Morisot, N ^a   Ben Hamida, S ^a,d   Ron, D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; GLYCOGEN SYNTHASE KINASE 3BETA; LACOSAMIDE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; ACETAMIDE DERIVATIVE; ALCOHOL; COLLAPSIN RESPONSE MEDIATOR PROTEIN-2; GLYCOGEN SYNTHASE KINASE 3; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; NERVE PROTEIN; SIGNAL PEPTIDE; TARGET OF RAPAMYCIN KINASE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRMP 2 GENE; DRINKING BEHAVIOR; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE INDUCTION; GENE SILENCING; MALE; MICROTUBULE; MOLECULAR PATHOLOGY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; RNA TRANSLATION; RODENT; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DENDRITE; LONG EVANS RAT; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN SYNTHESIS;

ACETAMIDES; ALCOHOL DRINKING; ANIMALS; DENDRITES; ETHANOL; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICROTUBULES; MULTIPROTEIN COMPLEXES; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; RATS; RATS, LONG-EVANS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84960158036     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2017.252     Document Type: Erratum

References (69)

1. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010; 35: 217-238.
2. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006; 29: 565-598.
3. Santini E, Huynh TN, Klann E. Mechanisms of translation control underlying long-lasting synaptic plasticity and the consolidation of long-term memory. Prog Mol Biol Transl Sci 2014; 122: 131-167.
4. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12: 21-35.
5. Buffington SA, Huang W, Costa-Mattioli M. Translational control in synaptic plasticity and cognitive dysfunction. Annu Rev Neurosci 2014; 37: 17-38.
6. Jung H, Gkogkas CG, Sonenberg N, Holt CE. Remote control of gene function by local translation. Cell 2014; 157: 26-40.
7. Brunn GJ, Hudson CC, Sekulic A, Williams JM, Hosoi H, Houghton PJ et al. Phos-phorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 1997; 277: 99-101.
8. Holz MK, Ballif BA, Gygi SP, Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 2005; 123: 569-580.
9. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136: 731-745.
10. Aitken CE, Lorsch JR. A mechanistic overview of translation initiation in eukar-yotes. Nat Struct Mol Biol 2012; 19: 568-576.
11. Neasta J, Barak S, Hamida SB, Ron D. mTOR complex 1: a key player in neuroa-daptations induced by drugs of abuse. J Neurochem 2014; 130: 172-184.
12. Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov 2011; 10: 868-880.
13. Neasta J, Ben Hamida S, Yowell Q, Carnicella S, Ron D. Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders. Proc Natl Acad Sci USA 2010; 107: 20093-20098.
14. Barak S, Liu F, Ben Hamida S, Yowell QV, Neasta J, Kharazia V et al. Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse. Nat Neurosci 2013; 16: 1111-1117.
15. Takei N, Inamura N, Kawamura M, Namba H, Hara K, Yonezawa K et al. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal den-drites. J Neurosci 2004; 24: 9760-9769.
16. Schratt GM, Nigh EA, Chen WG, Hu L, Greenberg ME. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J Neurosci 2004; 24: 7366-7377.
17. Morita T, Sobue K. Specification of neuronal polarity regulated by local translation of CRMP2 and Tau via the mTOR-p70S6K pathway. J Biol Chem 2009; 284: 27734-27745.
18. Loreni F, Iadevaia V, Tino E, Caldarola S, Amaldi F. RACK1 mRNA translation is regulated via a rapamycin-sensitive pathway and coordinated with ribosomal protein synthesis. FEBS Lett 2005; 579: 5517-5520.
19. Tang SJ, Reis G, Kang H, Gingras AC, Sonenberg N, Schuman EM. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci USA 2002; 99: 467-472.
20. Korb E, Finkbeiner S. Arc in synaptic plasticity: from gene to behavior. Trends Neurosci 2011; 34: 591-598.
21. Hell JW. CaMKII: claiming center stage in postsynaptic function and organization. Neuron 2014; 81: 249-265.
22. Derkach VA, Oh MC, Guire ES, Soderling TR. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev Neurosci 2007; 8: 101-113.
23. Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 2013; 14: 383-400.
24. Shiraishi-Yamaguchi Y, Furuichi T. The Homer family proteins. Genome Biol 2007; 8: 206.
25. Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 2004; 5: 771-781.
26. Adams DR, Ron D, Kiely PA. RACK1, A multifaceted scaffolding protein: structure and function. Cell Commun Signal 2011; 9: 22.
27. Ip JP, Fu AK, Ip NY. CRMP2: functional roles in neural development and therapeutic potential in neurological diseases. Neuroscientist 2014; 20: 589-598.
28. Beguin C, Potter DN, Carlezon WA Jr., Stohr T, Cohen BM. Effects of the antic-onvulsant lacosamide compared to valproate and lamotrigine on cocaine-enhanced reward in rats. Brain Res 2012; 1479: 44-51.
29. Ben Hamida S, Neasta J, Lasek AW, Kharazia V, Zou M, Carnicella S et al. The small g protein h-ras in the mesolimbic system is a molecular gateway to alcohol-seeking and excessive drinking behaviors. J Neurosci 2012; 32: 15849-15858.
30. del Prete MJ, Vernal R, Dolznig H, Mullner EW, Garcia-Sanz JA. Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. RNA 2007; 13: 414-421.
31. Darcq E, Warnault V, Phamluong K, Besserer GM, Liu F, Ron D. MicroRNA-30a-5p in the prefrontal cortex controls the transition from moderate to excessive alcohol consumption. Mol Psychiatry 2015; 20: 1240-1250.
32. Gibb SL, Hamida SB, Lanfranco MF, Ron D. Ethanol-induced increase in Fyn kinase activity in the dorsomedial striatum is associated with subcellular redistribution of protein tyrosine phosphatase alpha. J Neurochem 2011; 119: 879-889.
33. Brittain JM, Piekarz AD, Wang Y, Kondo T, Cummins TR, Khanna R. An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J Biol Chem 2009; 284: 31375-31390.
34. Lasek AW, Janak PH, He L, Whistler JL, Heberlein U. Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice. Genes Brain Behav 2007; 6: 728-735.
35. Carnicella S, Amamoto R, Ron D. Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor. Alcohol 2009; 43: 35-43.
36. Warnault V, Darcq E, Levine A, Barak S, Ron D. Chromatin remodeling- A novel strategy to control excessive alcohol drinking. Transl Psychiatry 2013; 3: e231.
37. Ben Hamida S, Darcq E, Wang J, Wu S, Phamluong K, Kharazia V et al. Protein tyrosine phosphatase alpha in the dorsomedial striatum promotes excessive ethanol-drinking behaviors. J Neurosci 2013; 33: 14369-14378.
38. Carnicella S, Ron D, Barak S. Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse. Alcohol 2014; 48: 243-252.
39. Barak S, Carnicella S, Yowell QV, Ron D. Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking. J Neurosci 2011; 31: 9885-9894.
40. NIAAA. Council approves definition of binge drinking. NIAAA Newsletter 2004; 3.
41. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012; 485: 109-113.
42. Peng J, Kim MJ, Cheng D, Duong DM, Gygi SP, Sheng M. Semiquantitative pro-teomic analysis of rat forebrain postsynaptic density fractions by mass spectro-metry. J Biol Chem 2004; 279: 21003-21011.
43. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 2005; 120: 137-149.
44. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129: 1261-1274.
45. Neasta J, Ben Hamida S, Yowell QV, Carnicella S, Ron D. AKT signaling pathway in the nucleus accumbens mediates excessive alcohol drinking behaviors. Biol Psychiatry 2011; 70: 575-582.
46. Tan M, Ma S, Huang Q, Hu K, Song B, Li M. GSK-3alpha/beta-mediated phosphorylation of CRMP-2 regulates activity-dependent dendritic growth. J Neurochem 2013; 125: 685-697.
47. Dent EW, Baas PW. Microtubules in neurons as information carriers. J Neurochem 2014; 129: 235-239.
48. Shirao T, Gonzalez-Billault C. Actin filaments and microtubules in dendritic spines. J Neurochem 2013; 126: 155-164.
49. Caroni P, Donato F, Muller D. Structural plasticity upon learning: regulation and functions. Nat Rev Neurosci 2012; 13: 478-490.
50. Nyberg F. Structural plasticity of the brain to psychostimulant use. Neuro-pharmacology 2014; 87: 115-124.
51. Wilson SM, Xiong W, Wang Y, Ping X, Head JD, Brittain JM et al. Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization. Neuroscience 2012; 210: 451-466.
52. Wilson SM, Khanna R. Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide. Mol Neurobiol 51: 599-609.
53. Higgins GA, Breysse N, Undzys E, Kuo C, Joharchi N, Derksen DR et al. The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodents. Eur J Pharmacol 2009; 624: 1-9.
54. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci 2007; 8: 844-858.
55. Pandey SC, Zhang H, Ugale R, Prakash A, Xu T, Misra K. Effector immediate-early gene arc in the amygdala plays a critical role in alcoholism. J Neurosci 2008; 28: 2589-2600.
56. Wang J, Ben Hamida S, Darcq E, Zhu W, Gibb SL, Lanfranco MF et al. Ethanol-mediated facilitation of AMPA receptor function in the dorsomedial striatum: implications for alcohol drinking behavior. J Neurosci 2012; 32: 15124-15132.
57. Easton AC, Lucchesi W, Lourdusamy A, Lenz B, Solati J, Golub Y et al. alphaCaMKII autophosphorylation controls the establishment of alcohol drinking behavior. Neuropsychopharmacology 2013; 38: 1636-1647.
58. Szumlinski KK, Ary AW, Lominac KD. Homers regulate drug-induced neuroplas-ticity: implications for addiction. Biochem Pharmacol 2008; 75: 112-133.
59. Camp MC, Feyder M, Ihne J, Palachick B, Hurd B, Karlsson RM et al. A novel role for PSD-95 in mediating ethanol intoxication, drinking and place preference. Addict Biol 2011; 16: 428-439.
60. Logrip ML, Barak S, Warnault V, Ron D. Corticostriatal BDNF and alcohol addiction. Brain Res 2015; 1628: 60-67.
61. Zhu LQ, Zheng HY, Peng CX, Liu D, Li HL, Wang Q et al. Protein phosphatase 2A facilitates axonogenesis by dephosphorylating CRMP2. J Neurosci 2010; 30: 3839-3848.
62. Cole AR, Soutar MP, Rembutsu M, van Aalten L, Hastie CJ, McLauchlan H et al. Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation. J Biol Chem 2008; 283: 18227-18237.
63. Lin PC, Chan PM, Hall C, Manser E. Collapsin response mediator proteins (CRMPs) are a new class of microtubule-associated protein (MAP) that selectively interacts with assembled microtubules via a taxol-sensitive binding interaction. J Biol Chem 2011; 286: 41466-41478.
64. Hoogenraad CC, Akhmanova A. Dendritic spine plasticity: new regulatory roles of dynamic microtubules. Neuroscientist 2010; 16: 650-661.
65. Quach TT, Honnorat J, Kolattukudy PE, Khanna R, Duchemin AM. CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases. Mol Psychiatry 2015; 20: 1037-1045.
66. DePoy L, Daut R, Brigman JL, MacPherson K, Crowley N, Gunduz-Cinar O et al. Chronic alcohol produces neuroadaptations to prime dorsal striatal learning. Proc Natl Acad Sci USA 2013; 110: 14783-14788.
67. Wang J, Cheng Y, Wang X, Hellard ER, Ma T, Gil H et al. Alcohol elicits functional and structural plasticity selectively in dopamine D1 receptor-expressing neurons of the dorsomedial striatum. J Neurosci 2015; 35: 11634-11643.
68. Wang Y, Brittain JM, Jarecki BW, Park KD, Wilson SM, Wang B et al. In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation. J Biol Chem 2010; 285: 25296-25307.
69. Perucca E, Yasothan U, Clincke G, Kirkpatrick P. Lacosamide. Nat Rev Drug Discov 2008; 7: 973-974.